The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis

References

• Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Liao JK. Pleiotropic effects of statins. – Basic research and clinical perspectives. Circ J. 2010;74(5):818–826.
   PubMed Web of Science ®Google Scholar
• Lahera V, Goicoechea M, De Vinuesa SG, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem. 2007;14(2):243–248. doi:10.2174/092986707779313381.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yan J, Chen X, et al. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol. 2011;230(1):27–34. doi:10.1016/j.expneurol.2010.04.006.
   PubMed Web of Science ®Google Scholar
• Schmeer C, Kretz A, Isenmann S. Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins. Restor Neurol Neurosci. 2006;24(2):79–95.
   PubMed Web of Science ®Google Scholar
• Morishita S, Oku H, Horie T, et al. Systemic simvastatin rescues retinal ganglion cells from optic nerve injury possibly through suppression of astroglial NF-kappaB activation. PLoS One. 2014;9(1):e84387. doi:10.1371/journal.pone.0084387.
   PubMed Web of Science ®Google Scholar
• Krempler K, Schmeer CW, Isenmann S, et al.. Simvastatin improves retinal ganglion cell survival and spatial vision after acute retinal ischemia/reperfusion in mice. Invest Ophthalmol Vis Sci. 2011;52(5):2606–2618. doi:10.1167/iovs.10-6005.
   PubMed Web of Science ®Google Scholar
• McGwin G Jr., McNeal S, Owsley C, et al. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol. 2004;122(6):822–826. doi:10.1001/archopht.122.6.822.
   PubMedGoogle Scholar
• Leung DY, Li FC, Kwong YY, et al. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology. 2010;117(3):471–476. doi:10.1016/j.ophtha.2009.08.016.
   PubMed Web of Science ®Google Scholar
• De Castro DK, Punjabi OS, Bostrom AG, et al. Effect of statin drugs and aspirin on progression in open angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol. 2007;35(6):506–513. doi:10.1111/j.1442-9071.2007.01529.x.
   PubMed Web of Science ®Google Scholar
• Stein JD, Newman-Casey PA, Talwar N, et al. The relationship between statin use and open angle glaucoma. Ophthalmology. 2012;119(10):2074–2081. doi:10.1016/j.ophtha.2012.04.029.
   PubMed Web of Science ®Google Scholar
• Marcus MW, Muskens RP, Ramdas WD, et al. Cholesterol-lowering drugs and incident open angle glaucoma: a population-based cohort study. PLoS One. 2012;7(1):e29724. doi:10.1371/journal.pone.0029724.
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Walker JH, Desjardins O, et al. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study. Curr Med Res Opin. 2009;25(8):1879–1888. doi:10.1185/03007990903035083.
   PubMed Web of Science ®Google Scholar
• Owen CG, Carey IM, Shah S, et al. Hypotensive medication, statins, and the risk of glaucoma. Invest Ophthalmol Vis Sci. 2010;51(7):3524–3530. doi:10.1167/iovs.09-4821.
   PubMed Web of Science ®Google Scholar
• Newgard CD, Hedges JR, Arthur M, et al. Advanced statistics: the propensity score–a method for estimating treatment effect in observational research. Acad Emerg Med. 2004;11(9):953–961.
   PubMed Web of Science ®Google Scholar
• Harder VS, Stuart EA, Anthony JC. Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods. 2010;15(3):234–249. doi:10.1037/a0019623.
   PubMed Web of Science ®Google Scholar
• Austin PC, Grootendorst P, Normand SL, et al. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study. Stat Med. 2007;26(4):754–768. doi:10.1002/sim.2618.
   PubMed Web of Science ®Google Scholar
• Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–398. doi:10.1016/S0895-4356(00)00321-8.
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786.
   PubMed Web of Science ®Google Scholar
• Bakas T, Lewis RR, Parsons JE. Caregiving tasks among family caregivers of patients with lung cancer. Oncol Nurs Forum. 2001;28(5):847–854.
   PubMedGoogle Scholar
• Lee PP, Levin LA, Walt JG, et al. The impact of glaucoma coding in a large claims database. Am J Ophthalmol. 2007;143(5):867–870. doi:10.1016/j.ajo.2006.12.034.
   PubMed Web of Science ®Google Scholar
• Hattenhauer MG, Johnson DH, Ing HH, et al. Probability of filtration surgery in patients with open angle glaucoma. Arch Ophthalmol. 1999;117(9):1211–1215. doi:10.1001/archopht.117.9.1211.
   PubMedGoogle Scholar
• Wilson MR. Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies. Trans Am Ophthalmol Soc. 2002;100:365–410.
   PubMedGoogle Scholar
• Nagaoka T, Takahashi A, Sato E, et al. Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol. 2006;124(5):665–670. doi:10.1001/archopht.124.5.665.
   PubMedGoogle Scholar
• Ho H, Shi Y, Chua J, et al. Association of systemic medication use with intraocular pressure in a multiethnic Asian population: the Singapore epidemiology of eye diseases study. JAMA Ophthalmol. 2017;135(3):196–202.
   PubMed Web of Science ®Google Scholar
• McCann P, Hogg RE, Fallis R, et al. The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: A systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2016;57(6):2729–2748. doi:10.1167/iovs.15-18595.
   PubMed Web of Science ®Google Scholar
• Kim C, Kim TW. Comparison of risk factors for bilateral and unilateral eye involvement in normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2009;50(3):1215–1220. doi:10.1167/iovs.08-1886.
   PubMed Web of Science ®Google Scholar
• Leung DY, Tham CC, Li FC, et al. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study. Ophthalmology. 2009;116(7):1250–1256. doi:10.1016/j.ophtha.2009.02.003.
   PubMed Web of Science ®Google Scholar
• Ho JD, Hu CC, Lin HC. Open-angle glaucoma and the risk of stroke development: a 5-year population-based follow-up study. Stroke. 2009;40(8):2685–2690. doi:10.1161/STROKEAHA.109.554642.
   PubMed Web of Science ®Google Scholar
• Stroke Council, American Heart Association, American Stroke Association. Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. Stroke. 2004;35(4):1023.
   PubMed Web of Science ®Google Scholar
• McClure DL, Valuck RJ, Glanz M, et al. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiol Drug Saf. 2007;16(2):132–143. doi:10.1002/pds.1341.
   PubMed Web of Science ®Google Scholar